Cargando…

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

BACKGROUND: Alosetron is approved to treat women with severe IBS and diarrhea (IBS-D) who have failed standard therapy. In our study, we aimed to evaluate alosetron efficacy using new US Food and Drug Administration (FDA) endpoints and utilization in clinical practice. METHODS: This prospective, ope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacy, Brian E., Nicandro, Jean Paul, Chuang, Emil, Earnest, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949923/ https://www.ncbi.nlm.nih.gov/pubmed/29774051 http://dx.doi.org/10.1177/1756284818771674

Ejemplares similares

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
por: Cremonini, F, et al.
Publicado: (2012)

Regional brain activation during rectal distention and attenuation with alosetron in a nonhuman primate model of irritable bowel syndrome
por: Fujii, Rintaro, et al.
Publicado: (2022)

Urgency as an Endpoint in Irritable Bowel Syndrome
por: Mangel, Allen W., et al.
Publicado: (2011)

Anti-inflammatory effects of alosetron mediated through 5-HT(3) receptors on experimental colitis
por: Motavallian, Azadeh, et al.
Publicado: (2019)

Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration
por: Gopalakrishnan, Mathangi, et al.
Publicado: (2020)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Trends in endpoint use in pivotal trials and efficacy for US Food and Drug Administration–approved solid tumor therapies, 1995-2021
por: Alabaku, Orges, et al.
Publicado: (2022)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation
por: Karthik, Yamjala, et al.
Publicado: (2015)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary
por: Wright-McNaughton, Morag, et al.
Publicado: (2019)

Inter-Rater Reliability of Provider Interpretations of Irritable Bowel Syndrome Food and Symptom Journals
por: Zia, Jasmine, et al.
Publicado: (2017)

Can Certain Foods Cause Gastrointestinal Symptoms in Korean Patients With Irritable Bowel Syndrome?
por: Nam, Kwangwoo, et al.
Publicado: (2019)

Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
por: Lacy, Brian E., et al.
Publicado: (2017)

Effectiveness of Menthacarin on symptoms of irritable bowel syndrome
por: Madisch, Ahmed, et al.
Publicado: (2018)

Impact of Diet on Symptoms of the Irritable Bowel Syndrome
por: Spiller, Robin
Publicado: (2021)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

The Significance of Information Posted on the U.S. Food and Drug Administration’s Website
por: Cook, G. Elliott, et al.
Publicado: (2013)

Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review
por: Okawa, Yohei, et al.
Publicado: (2019)

Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome
por: Lacy, Brian E.
Publicado: (2018)

Methylglyoxal Induces Systemic Symptoms of Irritable Bowel Syndrome
por: Zhang, Shuang, et al.
Publicado: (2014)

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions
por: Cangemi, David J., et al.
Publicado: (2019)

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome
por: Ahmed, Iftikhar, et al.
Publicado: (2013)

Manning Criteria in Irritable Bowel Syndrome: Its Diagnostic Significance
por: Jeong, Hyeok, et al.
Publicado: (1993)

High-Fat Foods and FODMAPs Containing Gluten Foods Primarily Contribute to Symptoms of Irritable Bowel Syndrome in Korean Adults
por: Na, Woori, et al.
Publicado: (2021)

Linaclotide Reduced Response Time for Irritable Bowel Syndrome With Constipation Symptoms: Analysis of 4 Randomized Controlled Trials
por: Brenner, Darren M., et al.
Publicado: (2023)

Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use
por: Uranga, José Antonio, et al.
Publicado: (2020)

Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome
por: Hong, Kyoung Sup, et al.
Publicado: (2009)

Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome
por: Hori, Kazutoshi, et al.
Publicado: (2009)

Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016)

How can probiotic improve irritable bowel syndrome symptoms?
por: Benjak Horvat, Indira, et al.
Publicado: (2021)

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
por: Wollny, Tomasz, et al.
Publicado: (2021)

Symptoms and health experience in irritable bowel syndrome with focus on men
por: Bureychak, Tetyana, et al.
Publicado: (2022)

Variation in Care for Patients with Irritable Bowel Syndrome in the United States
por: Lacy, Brian E., et al.
Publicado: (2016)

Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides
por: Ye, Yang, et al.
Publicado: (2022)

The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation
por: Singh, Prashant, et al.
Publicado: (2022)

Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
por: Pedersen, Natalia, et al.
Publicado: (2017)

Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease
por: Jalili, Mahsa, et al.
Publicado: (2016)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a81b9qq6gdp0n4k2fuacsmpunv